Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eas...

by Daniela Opris-Belinski, Shandor F Erdes, Simeon Grazio, Ladislav Šenolt, Maja Hojnik, Orsolya Nagy, Diana Marina, Sándor Szántó
Published 2018-11-01

Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial

by Désirée van der Heijde, Joachim Sieper, Walter P. Maksymowych, Robert G. Lambert, Su Chen, Maja Hojnik, Jaclyn K. Anderson, Aileen L. Pangan
Published 2018-03-01